Abstract
The incidence of helicobacter infections in human population appears not to have significantly wane over the years. Even though there are reports indicating that the prevalence rate is reducing in the developed world, constant migration, general globalization and other environmental factors has kept every population a risk. Moreover, the rising incidence of infection with non-pylori helicobacter species, which were considered hitherto non-virulent, puts a question in the seemingly progress made so far in the treatment and eradication of these bacteria and their infections. The purpose of this mini review is to access the clinical and epidemiological gains and the challenges so far in the treatment and eradication of helicobacter spp. infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
